Delivery Order SPE2DB20D9331-SPE2DB23FL0D0
Award Date
10/25/22
Potential Completion Date
11/16/22
Potential Value
$2.2K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,654.44 firm fixed-price delivery order contract is for the provision of TISSUEBLUE 0.025% SYRINGE 0.5ML, a specialized pharmaceutical product. The contract does not have a set-aside designation. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a firm fixed-price delivery order valued at $4,816.44 under the Defense Logistics Agency's (DLA) SPE2DB indefinite delivery contract (IDC). The IDC, valued at up to $499,999,999, covers a comprehensive range of pharmaceutical products and medical supplies to fulfill the recurring medical needs of Department of Defense (DoD) healthcare facilities worldwide. This delivery order,...
This federal contract award, with ID SPE2DB20D9331 and SPE2DB23FL1M2, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,088.56 firm fixed-price delivery order is for the supply of TISSUEBLUE 0.025% SYRINGE 0.5ML, a pharmaceutical product, with a completion date of September 21, 2023. This award is part of a larger indefinite delivery contract (IDC) valued at up to...
This federal contract award (SPE2DX15D9168|SPE2DX24F6XCQ) was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business in Park Ridge, Illinois. The $4,013.70 firm fixed-price delivery order is for the supply of TISSUEBLUE 0.025% SYRINGE 0.5ML and does not have a set-aside designation. The award is issued under DMS Pharmaceutical Group's existing indefinite delivery contract (4600082013) with the DLA, worth up to $4,999,999 through 2025, which...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $3,210.96, is for the supply of a pharmaceutical product, Tissueblue 0.025% Syringe 0.5ML, to support the recurring medical supply needs of military health facilities. The contract is part of a larger $499,999,999 indefinite delivery contract (IDC) awarded to...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $4,013.70 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of 0.5 mL syringes containing 0.025% Tissue Blue solution. This order is issued against DMS Pharmaceutical's indefinite delivery contract SPE2DB valued at up to $4,999,999 through 2025, which enables DLA to procure a broad range of pharmaceutical products for...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, was issued by the Defense Logistics Agency (DLA) for the Medical Supply Chain division. The $22,835.25 firm fixed-price delivery order is part of a larger $499,999,999 single-award indefinite delivery contract (IDC) that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. This IDC allows the DLA to issue delivery orders for a comprehensive range of...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the supply of pharmaceutical products including medications and medical supplies. The delivery order, valued at $2,494.50, has a completion date of September 13, 2022. This order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group worth up to $499,999,999, which allows the DLA to issue...
This is a $10,226.66 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to DMS Pharmaceutical Group Inc., a woman-owned small business. The order is placed against DMS Pharmaceutical Group's existing DLA contract 4600082013 under the SPE2DB program, valued at up to $4,999,999 through 2025. This allows DLA to issue delivery orders for a wide range of pharmaceutical products such as injectable medications, creams, solutions, and contraceptives to...
This federal contract award, valued at $4,227.90, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the provision of a specialized pharmaceutical product, 4567758624 ! VISIONBLUE 0.06% SYRINGE 0.5ML, to support the medical supply needs of military healthcare facilities. DMS Pharmaceutical Group Inc. holds a significant...